We are witnessing an event of some importance: the consideration by the Government to certain deviations in the drug industry.
"Cyclothymia and Truth" has long adhered to the warnings given by PRESCRIBE, the work of the investigative journalist Stéphane Horel or Pharmacritique excellent blog (see the websites in the "links").
Scandal Picks enabled the public and especially to the health authorities to realize certain present tendencies.
links between laboratories and health authorities, doctors and scientific textbook publishers will be more easily identifiable when professors Even and Debre chosen by the President of the Republic have submitted their report to the Minister of Health, Mr. Bertrand. Take time to watch this interview: from = # http://www.dailymotion.com/video/xah2j7_philippe-even_news embed
The conflict of interest destroys the confidence of the patient's doctor and we must ask the right questions and require full transparency.
Afssaps, whose manager has more power, has published a list of drugs "under guard" including several used in psychiatry: Anti-depressants (fluoxetine, sertraline), Ritalin Concerta, Quasym, Stablon, Stilnox, Zypradhera, Cymbalta, Noctram, Rohypsol ... Here is the official list
complete: http://www.lexpress.fr/actualite/sciences/sante/la-liste-des-77-medicaments-surveilles-par-l-afssaps_957770.html
These drugs are not prohibited but are subject to "enhanced surveillance" of the health authorities ...
I am glad that people who suffer from bipolar disorder or cyclothymia can find answers to their questions and sometimes effective therapies.
However, I remain very cautious on the label "manic" or "bipolar" because that ends the temperament and where the pathology starts?
Personally, I think we need to evaluate the episodes, TS, hospitalizations, serious shortcomings in terms of professional life, an episode of depression (not depression) and mania-hypomania (not hyperthymic).
Drugs are a big help in helping patients, but many questions remain unanswered: Who
takes these drugs, especially when and for how long? What side effects? Same problem with children and adolescents ( http://www.afssaps.fr/Dossiers-thematiques/Traitements-par-antidepresseurs/Traitement-par-antidepresseurs/ (offset) / 0 ).
WMA and "off-label" should be discussed and clarified in my opinion. We do not like the English guideline (NICE and the reference at the bottom of the depression on p.21: http://guidance.nice.org.uk/CG90/NICEGuidance/pdf/English ) or U.S. Senator Grassley!
recomande So I very carefully and take the time to learn.
You will find in this blog and in my synthesis published in 2009 Pharmacritique ( http://pharmacritique.20minutes-blogs.fr/archive/2009/06/23/cyclothymie-et-psychodiversite-les-traitements-en- question.html ), leads to serious reflection.
0 comments:
Post a Comment